RBC Capital Maintains Emera at Outperform, Lowers Price Target
RBC Capital has maintained its 'Outperform' rating on Emera Incorporated while adjusting its price target for the company's shares.
Stocks · News reference
Emera Reports Q3 Results and Unveils C$21.5 Billion Five-Year Capital Plan
Emera Inc. reported its third-quarter financial results and announced a new C$21.5 billion five-year capital investment plan aimed at driving 7.5%-8.5% rate base growth.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Enbridge, Moderna On Deck Friday As Demand, Vaccine Pipeline Face Test
Enbridge headlines Friday’s reports, with investors weighing whether resilient pipeline utilization can offset a softer revenue comparison. Moderna, Brookfield Asset Management, Humana, Vistra, PPL, Plains All American
Barclays Maintains Equal-Weight on Emera, Lowers Price Target to $50
Barclays analyst Nicholas Campanella maintains Emera (NYSE:EMA) with a Equal-Weight and lowers the price target from $53 to $50.
Top 3 Utilities Stocks Which Could Rescue Your Portfolio This Month
Deep Fission, Emera and VivoPower are oversold utilities stocks with RSI readings near or below 30, presenting potential buying opportunities.
Barclays Maintains Equal-Weight on Emera, Lowers Price Target to $53
Barclays analyst Michael Lonegan maintains Emera (NYSE:EMA) with a Equal-Weight and lowers the price target from $55 to $53.
Emera Q2 Adj. EPS $0.50 Misses $0.56 Estimate, Sales $1.453B
Emera (NYSE:EMA) reported quarterly earnings of $0.50 per share which missed the analyst consensus estimate of $0.56 by 10.71 percent. The company reported $1.453 billion in sales this quarter.